The HIV in Europe initiative is governed by an independent steering committee. The Coordinating Centre is at CHIP, RegionH, Copenhagen, and the political secretariat at the EATG .The conditions of funding the initiative are approved by the Steering Committee. Industry sponsors are invited to quarterly updates but do not participate in the Steering Committee.

Financial support of the HIV in Europe initiative provided by: Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Danish National Research Foundation (grant 126), European Commission under the 3rd  and 2nd Health Programmes,  European Centre for Disease Prevention and Control (ECDC), Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Schering-Plough, Swedish Research Council, ViiV Healthcare and Tibotec.

Sponsors of HepHIV2017

Platinum partners

 Gilead Sciences, Inc. www.gilead.com 

Gold partners
 MSD www.msd.com  ViiV Healthcare www.viivhealthcare.com

Silver partner


 AbbVie www.abbvie.com


To the HepHIV 2017 Conference, the OptTEST Symposium received funding from:

 OptTEST www.opttest.eu

Additional conference support from:

 Cepheid www.cepheid.com  

The HepHIV 2017 conference was endorsed by:
 AIDS Action Europe www.aidsactioneurope.org   Alliance for Public Health www.aph.org.ua
Correlation Hepatitis C Initiative www.correlation-net.org
  European AIDS Clinical Society www.eacsociety.org
  European Association for the Study of the liver www.easl.eu   European AIDS Treatment Group www.eatg.org
Eurasian Harm Reduction Network www.harm-reduction.org